Geng et al. reported that REG1α could be used as a marker of prognosis and recurrence in bladder cancer, and downregulation of REG1α reduced tumor growth, migration, invasion and angiogenesis [25]. This evidence concerns the gene REG1A and urinary bladder cancer.